betamethasone has been researched along with Melanoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, K; Kanno, H; Matsuyama, K; Mizuno, Y; Mochizuki, K; Nishida, T; Seishima, M; Takahashi, N; Takahashi, T; Yamada, W | 1 |
| Hata, H; Imafuku, K; Ohara, K; Tsuboi, S; Yamaguchi, K; Yoshino, K | 1 |
| Adler, NR; Brady, B; McCormack, C; Murray, WK; Pan, Y | 1 |
| Aoi, N; Harada, Y; Kaneko, S; Morita, E; Murata, S | 1 |
| KAUFMAN, HE | 1 |
| Dvorák, R; Eckhardt, U | 1 |
| Penman, HG; Stringer, HC | 1 |
1 review(s) available for betamethasone and Melanoma
| Article | Year |
|---|---|
THE UVEA.
Topics: Anatomy; Arthritis; Autoantibodies; Betamethasone; Dexamethasone; Dihydroxyphenylalanine; Epidemiology; Histoplasmosis; Hypersensitivity; Melanoma; Mercaptopurine; Oxyphenbutazone; p-Methoxy-N-methylphenethylamine; Phenothiazines; Physiology; Prednisolone; Prednisone; Sarcoidosis; Toxicology; Toxoplasmosis; Triamcinolone; Uvea; Uveitis; Virus Diseases | 1964 |
6 other study(ies) available for betamethasone and Melanoma
| Article | Year |
|---|---|
Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
Topics: Administration, Ophthalmic; Antibodies, Monoclonal; Antineoplastic Agents; Betamethasone; Female; Glucocorticoids; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Melanoma; Middle Aged; Nephritis, Interstitial; Nivolumab; Ophthalmic Solutions; Prednisone; Programmed Cell Death 1 Receptor; Self Tolerance; Skin; Tomography, X-Ray Computed; Uveitis | 2017 |
Case of successfully switching from nivolumab to vemurafenib with oral corticosteroids.
Topics: Administration, Oral; Aged; Betamethasone; Drug Eruptions; Drug Substitution; Female; Glucocorticoids; Humans; Melanoma; Nivolumab; Skin Neoplasms; Treatment Outcome; Vemurafenib | 2018 |
Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma.
Topics: Aged; Antineoplastic Agents, Immunological; Betamethasone; Glucocorticoids; Humans; Ipilimumab; Male; Melanoma; Neoplasm Metastasis; Prednisolone; Skin Neoplasms; Sweet Syndrome | 2018 |
Case of de novo psoriasis possibly triggered by nivolumab.
Topics: Administration, Cutaneous; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Betamethasone; Calcitriol; Drug Combinations; Humans; Male; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Nivolumab; Programmed Cell Death 1 Receptor; Psoriasis; Signal Transduction; Th1 Cells; Th17 Cells | 2017 |
[Ultrastructural changes in Harding-Passey melanoma by transfer to xenogeneic hosts. I. Tumour implantation into the anterior eye chamber of rats and guinea-pigs].
Topics: Animals; Anterior Chamber; Betamethasone; Cyclophosphamide; Cytoplasm; Cytoplasmic Granules; Eye Neoplasms; Female; Guinea Pigs; Immunosuppression Therapy; Inclusion Bodies; Inclusion Bodies, Viral; Melanins; Melanoma; Mice; Mice, Inbred A; Mice, Inbred DBA; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Oncogenic Viruses; Rats; Ribosomes; Transplantation, Homologous | 1972 |
Malignant transformation in giant congenital pigmented nevus. Death in early childhood.
Topics: Age Factors; Autopsy; Betamethasone; Cell Transformation, Neoplastic; Child, Preschool; Humans; Infant; Infant, Newborn; Male; Melanoma; Neoplasm Metastasis; Nevus, Pigmented; Scalp Dermatoses; Skin Neoplasms | 1971 |